DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
树突状细胞和 T 细胞在抗细菌 lg 反应中的作用
基本信息
- 批准号:7782763
- 负责人:
- 金额:$ 32.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAnti-Bacterial AgentsAntibodiesAntigensB-Lymphocyte SubsetsB-LymphocytesBacteriaBacterial PolysaccharidesBacterial ProteinsBacterial VaccinesBindingCD4 Positive T LymphocytesCD40 LigandCell SeparationCell WallCellsCharacteristicsDataDendritic CellsDevelopmentElectronicsEmployee StrikesEnzyme-Linked Immunosorbent AssayExhibitsFoundationsFundingGenerationsGoalsHumoral ImmunitiesImageImmuneImmunityImmunizationImmunoglobulin GImmunoglobulin MImmunoglobulinsImmunologic MemoryImmunologicsIn SituIn VitroKineticsKnock-in MouseLightMediatingMemoryMicroscopicMorbidity - disease rateNaturePhysiologicalPlayPneumoniaPolysaccharidesPopulationProblem SolvingProductionProteinsReceptor SignalingReceptors, Antigen, B-CellRecruitment ActivityRelative (related person)ResearchRoleSerotypingSignal TransductionSpecificitySpeedSpleenSplenic TissueStreptococcus pneumoniaeT cell responseT-LymphocyteTestingTextTimeTransgenic MiceTransgenic OrganismsVaccinesWild Type Mouseadaptive immunityanti-IgGbasecell typedesignenzyme linked immunospot assayextracellularfunctional statusimprovedin vivoinsightmortalitynovelpathogenpneumococcal surface protein Aresponsespatiotemporal
项目摘要
Streptococcus pneumoniae (Pn)is an extracellular bacterium that is a major cause of global morbidity
and mortality. Systemic adaptive immunity to Pn is mediated by antibody, especially IgG specific for the
capsular polysaccharide (PS),but also for bacterial proteins. Our long-term goal is to elucidate the
cellular mechanismsthat underlie the distinct differences that exist between in vivo anti-PSand
anti-protein Ig responses to intact Pn, as a prerequisite to the development of improved vaccines.In
contrast to the current dogma, based on using purified PS antigens, that IgG anti-PS responses are T
cell-independent, we demonstrated that the IgG anti-PS response to intact Pn is heavily dependent on CD4+
T cells but nevertheless, still exhibits striking differences in kinetics, generation of memory, and the
functional roles of dendritic and T cells relative to the co-induced anti-protein response. In light of these
data, the central hypothesis that underlies our proposed research is that differential B cell receptor
signaling and/or involvement of functionally distinct B cell subsets are the key parametersthat
distinguish physiologic anti-PS and anti-protein Ig responses. We will demonstrate that these
parameters differentially impact on 1) the temporal compartmentalization of responding B cells within the
spleen, and 2) the cellular interactions of the responding B cells with other immune cell types. As a result we
will provide a mechanistic basis that will elucidate the observed differences in anti-PS and anti-protein
responses. The specific aims are to:
1. Determine the nature and relationships of B cell and dendritic cell subsets, and CD4+ T cells that
differentially mediate in vivo anti-PS and anti-protein Ig isotype responses to systemic immunization
with intact Pn. We will utilize high speed electronic cell sorting and adoptive transfer of wild-type and
genetically altered immune cells combined with ELISPOT and ELISA analyses of antigen-specific Ig isotype
production to accomplish thisaim.
2. Determine the mechanism by which B cells, DCs,and CD4+ T cells differentially orchestrate
anti-PS and anti-protein responses within a spatiotemporal context. We will utilize B cells from BCR
knock-in mice with Ig specificity for Pn-derived PS or protein antigens and T cells from CD4+ TCR
transgenic mice with specificity for a Pn-derived protein to accomplish this aim.These cells will be used to
conduct in vitro functional studies and confocal microscopic analyses of splenic tissue sections
post-immunization. These studies are the first to systematically determine the mechanisms that
distinguish anti-PS from anti-protein responses to an intact bacterium and provide novel basic
immunologic insights with direct relevanceto the development of anti-bacterial vaccines.
肺炎链球菌(PN)是一种细胞外细菌,是全球发病率的主要原因
和死亡率。对PN的系统性适应性免疫是由抗体介导的,尤其是特有的IgG
囊囊多糖(PS),也用于细菌蛋白。我们的长期目标是阐明
细胞机制是基于体内抗PSAND之间存在的明显差异
抗蛋白质Ig对完整PN的反应,作为改善疫苗的开发的先决条件。
与当前的教条形成对比,基于使用纯化的PS抗原,IgG抗PS反应是T
独立于细胞
T细胞,但尽管如此,仍然在动力学,记忆产生和
树突状和T细胞相对于共诱导的抗蛋白质反应的功能作用。鉴于这些
数据,是我们提出的研究基础的中心假设是差异B细胞受体
信号传导和/或功能不同的B细胞子集的参与是关键参数
区分生理抗PS和抗蛋白Ig反应。我们将证明这些
参数对1)响应B细胞的时间分室化的影响。
脾脏和2)反应B细胞与其他免疫细胞类型的细胞相互作用。结果我们
将提供机械基础,以阐明抗PS和抗蛋白的观察到的差异
回答。具体目的是:
1。确定B细胞和树突状细胞子集的性质和关系,以及CD4+ T细胞
差异介导体内抗PS和抗蛋白质Ig同种型对系统免疫的反应
完整的PN。我们将利用野生型的高速电子电池分类和产物转移
遗传改变的免疫细胞与ELISPOT和ELISA分析的抗原特异性Ig同种型结合
生产以完成此iaM。
2。确定B细胞,DC和CD4+ T细胞差异编排的机制
在时空的情况下,抗PS和抗蛋白质反应。我们将利用BCR的B细胞
具有PN衍生的PS或蛋白质抗原和CD4+ TCR的T细胞的Ig特异性的敲入小鼠
PN衍生蛋白具有特异性的转基因小鼠可以实现此目标。这些细胞将用于
进行体外功能研究和脾组织切片的共聚焦显微镜分析
免疫后。这些研究是第一个系统地确定的机制
区分抗PS和对完整细菌的抗蛋白质反应,并提供新的碱性
具有直接相关的免疫见解是抗菌疫苗的发展。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pneumococcal Surface Protein A Plays a Major Role in Streptococcus pneumoniae-Induced Immunosuppression.
- DOI:10.4049/jimmunol.1502709
- 发表时间:2016-05-01
- 期刊:
- 影响因子:0
- 作者:Saumyaa;Pujanauski L;Colino J;Flora M;Torres RM;Tuomanen E;Snapper CM
- 通讯作者:Snapper CM
A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.
- DOI:10.4049/jimmunol.181.12.8258
- 发表时间:2008-12-15
- 期刊:
- 影响因子:0
- 作者:Chen Q;Cannons JL;Paton JC;Akiba H;Schwartzberg PL;Snapper CM
- 通讯作者:Snapper CM
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
CpG 寡脱氧核苷酸的关键 DNA 侧翼序列(但不是 6 碱基 CpG 基序)可以用 RNA 替换,而不会导致 Toll 样受体 9 介导的活性发生量或质的变化。
- DOI:10.1016/j.cellimm.2005.01.010
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Sen,Goutam;Flora,Michael;Chattopadhyay,Gouri;Klinman,DennisM;Lees,Andrew;Mond,JamesJ;Snapper,CliffordM
- 通讯作者:Snapper,CliffordM
Autologous albumin enhances the humoral immune response to capsular polysaccharide covalently coattached to bacteria-sized latex beads.
- DOI:10.1002/eji.201344266
- 发表时间:2014-05
- 期刊:
- 影响因子:5.4
- 作者:Colino, Jesus;Duke, Leah;Snapper, Clifford M.
- 通讯作者:Snapper, Clifford M.
Distinct Immunologic Properties of Soluble Versus Particulate Antigens.
- DOI:10.3389/fimmu.2018.00598
- 发表时间:2018
- 期刊:
- 影响因子:7.3
- 作者:Snapper CM
- 通讯作者:Snapper CM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLIFFORD M SNAPPER其他文献
CLIFFORD M SNAPPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLIFFORD M SNAPPER', 18)}}的其他基金
(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
基于(聚)甘油磷酸盐的交叉保护性抗葡萄球菌疫苗
- 批准号:
8074028 - 财政年份:2010
- 资助金额:
$ 32.15万 - 项目类别:
(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
基于(聚)甘油磷酸盐的交叉保护性抗葡萄球菌疫苗
- 批准号:
7963436 - 财政年份:2010
- 资助金额:
$ 32.15万 - 项目类别:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
多糖缀合物和 EBV 疫苗的新型载体
- 批准号:
7537173 - 财政年份:2007
- 资助金额:
$ 32.15万 - 项目类别:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
多糖缀合物和 EBV 疫苗的新型载体
- 批准号:
7388052 - 财政年份:2007
- 资助金额:
$ 32.15万 - 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
树突状细胞和 T 细胞在抗细菌 lg 反应中的作用
- 批准号:
7219524 - 财政年份:2001
- 资助金额:
$ 32.15万 - 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
树突状细胞和 T 细胞在抗菌 Ig 反应中的作用
- 批准号:
6317430 - 财政年份:2001
- 资助金额:
$ 32.15万 - 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
树突状细胞和 T 细胞在抗菌 Ig 反应中的作用
- 批准号:
6870301 - 财政年份:2001
- 资助金额:
$ 32.15万 - 项目类别:
相似国自然基金
三种凤尾蕨属植物中吡咯生物碱及其抗菌和抗HCV病毒功能研究
- 批准号:82360689
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
基于乏氧增强型超声抗菌剂的细菌生物膜感染协同治疗研究
- 批准号:22375101
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于声动力的高效靶向抗菌剂开发及其用于幽门螺杆菌感染治疗的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非典型I-型聚酮类抗菌剂NFAT-133的芳构化机理
- 批准号:32211530074
- 批准年份:2022
- 资助金额:10 万元
- 项目类别:
脑靶向新型反义抗菌剂递送系统的构建、评价及其递送机理研究
- 批准号:82202575
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Netosis in Trauma mediated Acute Lung Injury
创伤介导的急性肺损伤中的网沉着
- 批准号:
10371817 - 财政年份:2021
- 资助金额:
$ 32.15万 - 项目类别:
Netosis in Trauma mediated Acute Lung Injury
创伤介导的急性肺损伤中的网沉着
- 批准号:
10678655 - 财政年份:2021
- 资助金额:
$ 32.15万 - 项目类别:
Control of regulatory T cells by IL-17 in colorectal cancer
IL-17 在结直肠癌中对调节性 T 细胞的控制
- 批准号:
10619017 - 财政年份:2021
- 资助金额:
$ 32.15万 - 项目类别:
Control of regulatory T cells by IL-17 in colorectal cancer
IL-17 在结直肠癌中对调节性 T 细胞的控制
- 批准号:
10414125 - 财政年份:2021
- 资助金额:
$ 32.15万 - 项目类别:
Control of regulatory T cells by IL-17 in colorectal cancer
IL-17 在结直肠癌中对调节性 T 细胞的控制
- 批准号:
10278329 - 财政年份:2021
- 资助金额:
$ 32.15万 - 项目类别: